<DOC>
	<DOCNO>NCT00559975</DOCNO>
	<brief_summary>To evaluate safety tolerability adjuvanted influenza vaccine combine CpG7909 three different dos CpG 7909 single intramuscular ( IM ) administration healthy adult . Safety assess observation symptom , physical examination finding laboratory safety testing .</brief_summary>
	<brief_title>Safety , Tolerability , Immunogenicity And CPG Dosage Finding Study Novartis CpG Adjuvanted Flu Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subject age 18 â‰¤40 year Any serious disease , hypersensitivity egg vaccine component , neurological symptom positive antibody test dsDNA , RF , ANA thyroid . Abnormal TSH blood sample collect screen visit ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Adjuvanted Influenza Vaccine</keyword>
</DOC>